PHARMACEUTICAL PREPARATION UTILIZED

Brand Owner (click to sort) Address Description
ALASIA SRZ Properties, Inc. c/o Schwarz Pharma, Inc. 6140 West Executive Drive Mequon WI 53092 PHARMACEUTICAL PREPARATION UTILIZED IN THE TREATMENT AND MANAGEMENT OF ANXIETY AND ANXIETY DISORDERS;
COPAR SRZ Properties, Inc. c/o Schwarz Pharma, Inc. 6140 West Executive Drive Mequon WI 53092 Pharmaceutical preparation utilized in the treatment of disorder related to Parkinson's Disease;
DOPAL SRZ Properties, Inc. c/o Schwarz Pharma, Inc. 6140 West Executive Drive Mequon WI 53092 Pharmaceutical preparation utilized in the treatment of disorder related to Parkinson's Disease;
NIRAVAM UCB MANUFACTURING, INC. 755 JEFFERSON ROAD ROCHESTER NY 14623 PHARMACEUTICAL PREPARATION UTILIZED IN THE TREATMENT AND MANAGEMENT OF ANXIETY AND ANXIETY DISORDERS;
PARCOPA UCB MANUFACTURING, INC. 755 JEFFERSON ROAD ROCHESTER NY 14623 Pharmaceutical preparation utilized in the treatment of disorder related to Parkinson's Disease;
QUIETAL SRZ Properties, Inc. c/o Schwarz Pharma, Inc. 6140 West Executive Drive Mequon WI 53092 PHARMACEUTICAL PREPARATION UTILIZED IN THE TREATMENT AND MANAGEMENT OF ANXIETY AND ANXIETY DISORDERS;QUIET ALL;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohol, triglyceride, partial glyceride and fatty acid ester.